| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.6M | -19.9% |
| Cost of Revenue | $1.3M | -27.3% |
| Gross Profit | $1.3M | -11.2% |
| R&D Expense | $3.2M | +39.6% |
| SG&A Expense | $15.3M | +46.0% |
| Operating Income | -$20.5M | -47.7% |
| Pre-tax Income | -$11.4M | -11.1% |
| Income Tax | -$19K | -146.3% |
| Net Income | -$11.4M | -10.5% |
| EPS (Basic) | -$0.57 | +39.4% |
| EPS (Diluted) | -$0.57 | +39.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $100.6M | -11.0% |
| Accounts Receivable | $300K | +8.7% |
| Current Assets | $120.1M | +5.6% |
| Total Assets | $120.9M | +5.3% |
| Current Liabilities | $23.9M | +270.6% |
| Total Liabilities | $24.6M | +223.1% |
| Stockholders' Equity | $96.3M | -10.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.5M | +6.3% |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $80K | -99.9% |